Plasma biomarkers of oxidative stress: Relationship to lung disease and inhaled nitric oxide therapy in premature infants

Philip L. Ballard, William E. Truog, Jeffrey D. Merrill, Andrew Gow, Michael Posencheg, Sergio G. Golombek, Lance A. Parton, Xianqun Luan, Avital Cnaan, Roberta A. Ballard

Результат исследований: Материалы для журналаСтатья

40 Цитирования (Scopus)

Выдержка

Objectives. Inhaled nitric oxide treatment for ventilated premature infants improves survival without bronchopulmonary dysplasia. However, there has been no information regarding possible effects of this therapy on oxidative stress. We hypothesized that inhaled nitric oxide therapy would not influence concentrations of plasma biomarkers of oxidative stress. Patients and Methods. As part of the Nitric Oxide Chronic Lung Disease Trial, we collected blood samples at specified intervals from a subpopulation of 100 infants of

Язык оригиналаАнглийский
Страницы (с-по)555-561
Число страниц7
ЖурналPediatrics
Том121
Номер выпуска3
DOI
СостояниеОпубликовано - мар 2008
Опубликовано для внешнего пользованияДа

Отпечаток

Premature Infants
Lung Diseases
Nitric Oxide
Oxidative Stress
Biomarkers
Bronchopulmonary Dysplasia
Chronic Disease
Therapeutics
Survival

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Цитировать

Ballard, P. L., Truog, W. E., Merrill, J. D., Gow, A., Posencheg, M., Golombek, S. G., ... Ballard, R. A. (2008). Plasma biomarkers of oxidative stress: Relationship to lung disease and inhaled nitric oxide therapy in premature infants. Pediatrics, 121(3), 555-561. https://doi.org/10.1542/peds.2007-2479

Plasma biomarkers of oxidative stress : Relationship to lung disease and inhaled nitric oxide therapy in premature infants. / Ballard, Philip L.; Truog, William E.; Merrill, Jeffrey D.; Gow, Andrew; Posencheg, Michael; Golombek, Sergio G.; Parton, Lance A.; Luan, Xianqun; Cnaan, Avital; Ballard, Roberta A.

В: Pediatrics, Том 121, № 3, 03.2008, стр. 555-561.

Результат исследований: Материалы для журналаСтатья

Ballard, PL, Truog, WE, Merrill, JD, Gow, A, Posencheg, M, Golombek, SG, Parton, LA, Luan, X, Cnaan, A & Ballard, RA 2008, 'Plasma biomarkers of oxidative stress: Relationship to lung disease and inhaled nitric oxide therapy in premature infants', Pediatrics, том. 121, № 3, стр. 555-561. https://doi.org/10.1542/peds.2007-2479
Ballard PL, Truog WE, Merrill JD, Gow A, Posencheg M, Golombek SG и соавт. Plasma biomarkers of oxidative stress: Relationship to lung disease and inhaled nitric oxide therapy in premature infants. Pediatrics. 2008 Март;121(3):555-561. https://doi.org/10.1542/peds.2007-2479
Ballard, Philip L. ; Truog, William E. ; Merrill, Jeffrey D. ; Gow, Andrew ; Posencheg, Michael ; Golombek, Sergio G. ; Parton, Lance A. ; Luan, Xianqun ; Cnaan, Avital ; Ballard, Roberta A. / Plasma biomarkers of oxidative stress : Relationship to lung disease and inhaled nitric oxide therapy in premature infants. В: Pediatrics. 2008 ; Том 121, № 3. стр. 555-561.
@article{2ba26867f5674c2bb0532a7cc3a9a230,
title = "Plasma biomarkers of oxidative stress: Relationship to lung disease and inhaled nitric oxide therapy in premature infants",
abstract = "Objectives. Inhaled nitric oxide treatment for ventilated premature infants improves survival without bronchopulmonary dysplasia. However, there has been no information regarding possible effects of this therapy on oxidative stress. We hypothesized that inhaled nitric oxide therapy would not influence concentrations of plasma biomarkers of oxidative stress. Patients and Methods. As part of the Nitric Oxide Chronic Lung Disease Trial, we collected blood samples at specified intervals from a subpopulation of 100 infants of",
keywords = "3-nitrotyrosine, Bronchopuimonary dysplasia, Carbonyl, Nitric oxide, Premature infant",
author = "Ballard, {Philip L.} and Truog, {William E.} and Merrill, {Jeffrey D.} and Andrew Gow and Michael Posencheg and Golombek, {Sergio G.} and Parton, {Lance A.} and Xianqun Luan and Avital Cnaan and Ballard, {Roberta A.}",
year = "2008",
month = "3",
doi = "10.1542/peds.2007-2479",
language = "English",
volume = "121",
pages = "555--561",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

TY - JOUR

T1 - Plasma biomarkers of oxidative stress

T2 - Relationship to lung disease and inhaled nitric oxide therapy in premature infants

AU - Ballard, Philip L.

AU - Truog, William E.

AU - Merrill, Jeffrey D.

AU - Gow, Andrew

AU - Posencheg, Michael

AU - Golombek, Sergio G.

AU - Parton, Lance A.

AU - Luan, Xianqun

AU - Cnaan, Avital

AU - Ballard, Roberta A.

PY - 2008/3

Y1 - 2008/3

N2 - Objectives. Inhaled nitric oxide treatment for ventilated premature infants improves survival without bronchopulmonary dysplasia. However, there has been no information regarding possible effects of this therapy on oxidative stress. We hypothesized that inhaled nitric oxide therapy would not influence concentrations of plasma biomarkers of oxidative stress. Patients and Methods. As part of the Nitric Oxide Chronic Lung Disease Trial, we collected blood samples at specified intervals from a subpopulation of 100 infants of

AB - Objectives. Inhaled nitric oxide treatment for ventilated premature infants improves survival without bronchopulmonary dysplasia. However, there has been no information regarding possible effects of this therapy on oxidative stress. We hypothesized that inhaled nitric oxide therapy would not influence concentrations of plasma biomarkers of oxidative stress. Patients and Methods. As part of the Nitric Oxide Chronic Lung Disease Trial, we collected blood samples at specified intervals from a subpopulation of 100 infants of

KW - 3-nitrotyrosine

KW - Bronchopuimonary dysplasia

KW - Carbonyl

KW - Nitric oxide

KW - Premature infant

UR - http://www.scopus.com/inward/record.url?scp=40949144900&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40949144900&partnerID=8YFLogxK

U2 - 10.1542/peds.2007-2479

DO - 10.1542/peds.2007-2479

M3 - Article

C2 - 18310205

AN - SCOPUS:40949144900

VL - 121

SP - 555

EP - 561

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

ER -